The Helix Blog

The Helix Blog gives voice to City of Hope graduate students and their research.

Saul Priceman | City of Hope

City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer

August 15, 2019 | Letisia Marquez

Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.

Continue Reading

Susan Neuhausen

Researcher Awarded $3M Grant to Study Genomics of Breast Cancer in Latinas

August 14, 2019 | Jenny Peters

City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.

Continue Reading

Yuman Fong | City of Hope

First in the nation: City of Hope to offer experimental T cell drug for liver cancer patients

August 5, 2019 | Zen Vuong

An ongoing clinical study in China on the drug showed liver tumor shrinkage, regression of metastatic tumors and fewer side effects than in other T cell clinical trials.

Continue Reading

Pancreatic Cancer Cell

Two new grants aim to advance pancreatic cancer treatment

July 24, 2019 | Cara Martinez

The Pancreatic Cancer Action Network has awarded two City of Hope researchers — Yuan Chen, Ph.D., and Xiaochun Yu, M.D., Ph.D. — $500,000 Translational Research Grants — a total gift of $1 million.

Continue Reading

Radiotherapy for Breast Cancer at City of Hope

Blood test could predict breast cancer relapse

July 8, 2019 | Zen Vuong

A special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.

Continue Reading

breakthroughs - t cells

ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL

June 28, 2019 | City of Hope

At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.

Continue Reading

Orange as Cancer Fighter | City of Hope

From Oranges, a Powerful Potential Cancer Fighter

June 13, 2019 | Wayne Lewis

Sharad Singhal, Ph.D., research professor in the Department of Medical Oncology and Therapeutics Research, leads investigations focusing on a small molecule that is abundant in the pith of citrus fruit.

Continue Reading

Back To Top